Equity Details
Price & Market Data
Price: $8.10
Daily Change: -$0.07 / 0.86%
Daily Range: $7.81 - $8.17
Market Cap: $74,318,200
Daily Volume: 63,827
Performance Metrics
1 Week: -6.58%
1 Month: 25.20%
3 Months: 11.50%
6 Months: -22.31%
1 Year: -31.09%
YTD: -5.58%
About Adicet Bio, Inc. (ACET)
Uncover market data for Adicet Bio, Inc. (ACET). Price: 8.10, daily change: -$0.07 / 0.86%. Market cap: 74,318,200. Performance from 1-week to 6-month.
Company Details
Employees: 102
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.